Capillary Technologies India Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Results
Capillary Technologies India share price Rs 445.90 on 17 September 2026, down 1.36%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 9.55 crore loss. Q2 FY26 base a profit of Rs 0.29 crore.
Quick Answer
The Capillary Technologies India Q2 results date for FY27 is not confirmed, and Capillary Technologies India Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 179.33 crore in revenue and a profit of Rs 0.29 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Capillary Technologies India Q2 results FY27 announcement is the next scheduled earnings event for Capillary Technologies India Ltd., Capillary Technologies India builds cloud-based customer loyalty and engagement software that retail and consumer brands use to run rewards programmes and personalised marketing.. The stock traded at Rs 445.90 on the NSE on 17 September 2026, down 1.36% from the previous close of Rs 452.05, about 44.2% below its 52-week high of Rs 798.95 and 1.8% above its 52-week low of Rs 438.15.
What makes the Capillary Technologies India Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 179.33 crore of revenue and a profit of Rs 0.29 crore, while the most recent quarter on record, Q1 FY27, produced Rs 256.64 crore and a loss of Rs 9.55 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Capillary Technologies India Q2 Results FY27 Date?
The Capillary Technologies India Q2 results date for FY27 is not confirmed. As of 17 September 2026, Capillary Technologies India Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
Also read – Nazara Technologies Q2 Results FY27 Preview: Results Date, Expectations
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Capillary Technologies India Q2 results date becomes public through that filing rather than through any advance announcement.
The Capillary Technologies India Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Capillary Technologies India.
Capillary Technologies India Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Capillary Technologies India Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Capillary Technologies India. The Capillary Technologies India Q2 results watchlist below is built from what the company has actually reported and disclosed.
The Capillary Technologies India Q2 results come only a few quarters after the company’s late-2025 listing, so the September 2026 quarter print will still be read against a short public track record. Revenue has grown steadily across the last five quarters, from Rs 179.89 crore in June 2025 to Rs 179.33 crore in September 2025, Rs 184.04 crore in December 2025, Rs 191.35 crore in March 2026 and Rs 256.64 crore in June 2026. Operating profit has grown alongside it, rising from Rs 17.84 crore to Rs 40.3 crore over the same period, so the core software business has been expanding on both counts. Net profit, however, has been far less consistent, jumping to Rs 43.36 crore in March 2026 before swinging to a net loss of about Rs 9.5 crore in June 2026, a pattern investors will want explained in the upcoming numbers.
Operating margin has actually improved through this stretch, moving from 9.92% in June 2025 to 15.70% in June 2026, which is a healthier trend than the net profit line suggests on its own. Return on equity of 2.95% and return on capital employed of 3.42% remain low in absolute terms, which is common for a software company still early in its life as a listed business and working through IPO-related costs. Software-as-a-service businesses in the customer engagement space often show this kind of gap between operating performance and reported net profit in their first few quarters as public companies, as one-off items and tax adjustments settle down, which is a useful frame for the Capillary Technologies India Q2 results. Keeping that operating margin trend in view is important context ahead of the Capillary Technologies India Q2 results.
Also read – Premier Energies Q2 Results FY27 Preview: Results Date, Expectations
Heading into the September 2026 quarter, the Capillary Technologies India Q2 results will likely focus on whether the Rs 9.5 crore net loss reported in June 2026 was a one-off event or the start of a pattern, especially since operating profit grew to Rs 40.3 crore in that same quarter. The Rs 43.36 crore net profit reported in March 2026 also stands out against the surrounding quarters and looks more like an exceptional item than a new steady-state level of earnings. Because both the March 2026 spike and the June 2026 loss sit below the operating profit line, they most likely reflect items such as tax adjustments, exceptional charges or IPO-related costs rather than a problem with the underlying business, which continued to grow revenue and operating profit into the September 2026 quarter.
Check Capillary Technologies India Ltd. Live Fundamentals on the Univest Screener
Capillary Technologies India Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Capillary Technologies India Ltd. reported revenue of Rs 256.64 crore in Q1 FY27, up 42.66% from Rs 179.89 crore in Q1 FY26, and a loss of Rs 9.55 crore at the net level, a swing from a profit of Rs 0.75 crore in Q1 FY26 to a loss of Rs 9.55 crore. These are reported actuals, not estimates.
Sequentially, revenue was up 34.12% over the March 2026 quarter figure of Rs 191.35 crore, and net profit was a swing from a profit of Rs 43.36 crore in Q4 FY26 to a loss of Rs 9.55 crore. Operating margin stood at 9.92% in Q1 FY27 against 10.4% in the September 2025 quarter, which is the comparison the Capillary Technologies India Q2 results print will be read against.
Q2 FY26 Base: The Comparison Capillary Technologies India Q2 Results FY27 Must Beat
Capillary Technologies India Ltd. reported revenue of Rs 179.33 crore and a profit of Rs 0.29 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Capillary Technologies India Q2 results preview.
Because the base quarter itself was loss-making, a year-on-year percentage comparison of profit is not meaningful for Capillary Technologies India. The more useful test in the Capillary Technologies India Q2 results print is whether the company reports a profit at all, and how the income line of Rs 179.33 crore compares with the Rs 256.64 crore of the June 2026 quarter.
Capillary Technologies India Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 179.33 | 0.29 |
| Q3 FY26 (Dec 2025) | 184.04 | 7.99 |
| Q4 FY26 (Mar 2026) | 191.35 | 43.36 |
| Q1 FY27 (Jun 2026) | 256.64 | (9.55) |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Capillary Technologies India Q2 results preview uses.
Revenue across those four quarters ranged from Rs 179.33 crore to Rs 256.64 crore, and net profit from Rs 9.55 crore loss to Rs 43.36 crore. That spread is the honest context for the Capillary Technologies India Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Capillary Technologies India Q2 Results FY27
The Capillary Technologies India Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Capillary Technologies India has already reported.
Steady Revenue And Operating Profit Growth
Both revenue and operating profit have risen in every one of the last five quarters, with revenue up from Rs 179.89 crore to Rs 256.64 crore and operating profit up from Rs 17.84 crore to Rs 40.3 crore. This consistent operating growth is a useful anchor for the Capillary Technologies India Q2 results, since it shows the core loyalty and engagement software business has kept expanding even while the net profit line has been volatile.
Net Profit Volatility Below The Operating Line
Net profit swung from Rs 7.99 crore in December 2025 to Rs 43.36 crore in March 2026 and then to a loss of about Rs 9.5 crore in June 2026, a far wider range than the steady growth seen in revenue and operating profit over the same quarters. Given that operating profit itself grew each quarter, this volatility most likely comes from below-the-line items such as tax charges, exceptional items or costs tied to the company’s IPO rather than from the core business slowing down, a distinction worth keeping in mind when reading the Capillary Technologies India Q2 results.
Early-Stage Return Ratios
Return on equity of 2.95% and return on capital employed of 3.42% are both modest, reflecting a company that listed recently and is still working through the early stages of being a public business. These ratios, along with the short quarterly history available, mean the Capillary Technologies India Q2 results will likely be judged more on the operating trend than on net profit alone until a longer track record builds up, a distinction that matters for the Capillary Technologies India Q2 results.
Capillary Technologies India Q2 Results FY27: Share Price and Valuation Going Into the Print
Capillary Technologies India share price today is Rs 445.90 on the NSE, down Rs 6.15 or 1.36% from the previous close of Rs 452.05 on 17 September 2026, ahead of the Capillary Technologies India Q2 results announcement.
| Metric | Value (17 September 2026) |
|---|---|
| NSE Symbol | CAPILLARY |
| Current Market Price | Rs 445.90 |
| 52-Week High | Rs 798.95 |
| 52-Week Low | Rs 438.15 |
| Market Capitalisation | Rs 3548 crore |
| PE Ratio | 69.26 |
| PB Ratio | 3.46 |
| EPS (TTM) | Rs 6.44 |
| Book Value per Share | Rs 129.00 |
| Debt to Equity | 0.05 |
| Return on Equity | 2.95% |
| 50-Day Moving Average | Rs 513.06 |
| 200-Day Moving Average | Rs 575.82 |
| RSI (14) | 20.72 |
The stock trades below both its 50-day average of Rs 513.06 and its 200-day average of Rs 575.82, with a 14-day RSI of 20.72. None of this is a view on where the shares go once the Capillary Technologies India Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Capillary Technologies India Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Capillary Technologies India Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Capillary Technologies India Q2 results print in proportion.
- Revenue against the Rs 179.33 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 0.29 crore in that same quarter
- Operating margin against 9.92% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Capillary Technologies India Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Capillary Technologies India Q2 Results FY27
The Capillary Technologies India Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Capillary Technologies India Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Capillary Technologies India Q2 results FY27 print faces a base of Rs 179.33 crore in revenue and a profit of Rs 0.29 crore, with the most recent quarter having delivered Rs 256.64 crore and a loss of Rs 9.55 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Capillary Technologies India, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Capillary Technologies India Q2 Results FY27
What is the Capillary Technologies India Q2 results date for FY27?
Ans. The Capillary Technologies India Q2 results date for FY27 is not confirmed. Capillary Technologies India Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Capillary Technologies India Q2 results 2026 cover?
Ans. The Capillary Technologies India Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Capillary Technologies India Ltd. reports revenue, operating profit and net profit for that period, and the Capillary Technologies India Q2 results filing also carries the notes to the accounts.
What were the Capillary Technologies India Q1 FY27 results?
Ans. Capillary Technologies India Ltd. reported revenue of Rs 256.64 crore in Q1 FY27 and a loss of Rs 9.55 crore at the net level. Revenue was up 42.66% versus Q1 FY26 and net profit was a swing from a profit of Rs 0.75 crore in Q1 FY26 to a loss of Rs 9.55 crore.
What were Capillary Technologies India Q2 FY26 results in the September 2025 quarter?
Ans. Capillary Technologies India Ltd. reported revenue of Rs 179.33 crore and a profit of Rs 0.29 crore in Q2 FY26. Operating margin was 10.4%. Those figures form the base for the Capillary Technologies India Q2 results FY27 comparison.
What are the main Capillary Technologies India Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Capillary Technologies India Q2 results expectations centre on revenue against the Rs 179.33 crore base, net profit against a profit of Rs 0.29 crore, operating margin against 9.92% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Capillary Technologies India share price today ahead of the Q2 earnings?
Ans. Capillary Technologies India share price is Rs 445.90 on the NSE as of 17 September 2026, down 1.36% from Rs 452.05. The stock is about 44.2% below its 52-week high of Rs 798.95 and 1.8% above its 52-week low of Rs 438.15, at a market capitalisation of Rs 3548 crore.
Is Capillary Technologies India a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Capillary Technologies India Ltd. The stock trades at a price-to-book ratio of 3.46 with a return on equity of 2.95%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
